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Genital samples from pregnant women were examined to determine the Candida species 
present and how some predisposing factors would affect the frequency of isolation of species. 
A total of 147 women (87 volunteer asymptomatic pregnant women and 60 asymptomatic non-
pregnant women) were examined. High Vaginal Swabs (HVS) were collected in pairs while 
demographic data (age of individual, age of pregnancy, occupation and use of contraceptive 
pill) on each subject were obtained alongside. Samples were cultured on Sabouraud Dextrose 
Agar plates and incubated for 72 hours at 37°C. Results revealed five Candida species 
(C.albicans, C.glabrata, C.tropicalis, C.stellatoidea, C.parapsilosis) with 61.5, 17.9, 7.7, 5.1, 2.6 % 
frequency of isolation respectively, as against 73.7, 7.7, 1.4, 11.3, and 0.0% for control.  Women in 
the second trimester of pregnancy had the highest occurrence (68.8%) while the age groups 24-
30 and 31-37 years had the highest occurrence in the control (46.2%) and  in the pregnant ones 
(51.7%) respectively. Traders had 68.8%, and full-time housewives, 26.7% occurrence. More 
women who used contraceptives had Candida (58.3%) as against non contraceptive users 
(35.3%). The results support literature reports that there are high rates of colonization of the 
vagina of pregnant women by Candida. They also give credence to earlier reports that the 
factors determined here affect the frequency of isolation of Candida species from the vagina. 
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Introduction 
Though members of the normal flora of 
the skin and mucosal surfaces of 
humans, several species of Candida are 
capable of causing candidiasis, as 
infection caused by Candida is called (1). 
Where they occur as normal flora, 
Candida species may gain dominance 
when there is a disruption of the normal 
flora balance of the body (as in the 
immunosuppressed, for example) 
producing progressive systemic disease 
(1). Some Candida species are also found 
in the soil and food (2).               92              
The fungus Candida lives in small 
numbers in a healthy vagina, rectum 
and mouth (3, 4). About 75% of women 
generally harbour this fungus without it 
causing harm to them (5,6). Some of the 
factors which predispose women to 
vaginal candidiasis are change in pH, 
use of oral contraceptives, tight 
clothing, and personal hygiene (4,7). 
However, it is reported that there is 
increase in occurrence of vaginal 
candidiasis during pregnancy due to 
increased levels of hormones such as  
 
oestrogen and steroid hormones (8). 
Candida infection in pregnancy does not 
usually harm the unborn child but 
causes great discomfort to the mother, 
which includes increased discharge, 
redness, itching, and burning sensation 
in the vulva area (9). If the disease is not 
treated the baby can get infected (oral 
thrush) at birth which can be a very 
serious health problem in premature 
babies. Also, untreated vaginal 
infections can lead to pelvic 
inflammatory disease, a condition 
which can scar the fallopian tube and 
cause infertility (10). The aim of this 
study was to determine the Candida 
species present in the vaginas of 
pregnant women attending two private 
hospitals in Benin City, and examine the 
role of age of subject, occupation, age of 
pregnancy and use of oral 
contraceptives on the occurrence of 
Candida. 
Materials and Methods 
Specimens: A total of 87 volunteer 
pregnant women attending antenatal 
clinic and 60 non-pregnant women at 
Suyi Hospital and Lahor Clinic both in 
Benin City, were screened. High 
Vaginal Swabs (HVS) were collected in 
pairs from individuals while 
demographic information such as age of 
individual, age of pregnancy, 
occupation, use of contraceptive pill, 
were also collected from the women 
alongside the specimens. For the 
controls (non pregnant women) absence 
of pregnancy was confirmed with the 
HCG Pregnancy Kit (Quimica Clinica 
Aplicada,S.A. Amposta,, Spain). 
Microscopic examination of specimens 
One swab from each pair was used for 
wet preparation direct mount under the 
x40 power of an optical microscope to 
detect the presence of blastospores and 
pseudohyphae, while the other swab 
was used to streak Sabouraud Dextrose 
Agar SDA (Oxoid, England) plates 
containing 0.5ml Chloramphenicol 
(500mg,Pfizer) and incubated at 370C in 
triplicates. Uninoculated plain agar 
plates served as control for the 
inoculated ones. Discrete yeast colonies 
were subcultured on fresh SDA slants in 
McCarthney bottles for identification 
and storage.  
Identification of Candida species: 
Specimens were identified using 
CHROMagar Candida (France) and API 
20C System (Analytab Products, USA) 
according to earlier procedures (11, 12). 
Statistical analysis: Chi-Square test was 
used to analyze the results. 
Results 
Five Candida species were isolated with 
varying distributions, namely, C 
.albicans (61.5, 73.7), C. glabrata (17.9, 
7.7), C. tropicalis (7.7, 1.4), C. stellatoidea 
(5.1, 11.3), C. parapsilosis (2.6, 0.0 %) for 
pregnant and non-pregnant women 
(control), respectively (Fig. 1). The mean 
frequencies of isolation of Candida from 
women in the first, second and third 
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 trimesters were 33, 68 and 30% respectively (Tab. I).
 
 





















































           TABLE I: OCCURRENCE OF CANDIDA SPECIES ACCORDING TO AGE OF PREGNANCY. 
 
 
Trimester (weeks)          Sample size          positive cultures              Positive cultures 
                                                                     No.           %                % in total (87) samples 
First (0 -12)                  6                              2             33.3                  2.3 
Second (13 -26)           32                            22            68.8                 25.3 






                  TABLE II:  AGE DISTRIBUTION OF PATIENTS WITH CANDIDA SPECIES 
 
Age (years)      Sample size      No. of positive cultures                    % of positive cultures 
                     Exper..   Control     Exper.       Control                      Exper.              Control 
17-23             29           20           15                 7                              51.7                  35 
24-30              46          26            20                12                            43.5                  46.2 
31-37              11           13            4                  6                              36.4                  46.2 








TABLE III: OCCURRENCE OF CANDIDA SPECIES IN VARIOUS OCCUPATIONAL GROUPS 
 
 
Occupation        Sample size                              Positive cultures (No. and %) 
                          Exper.    Control                         Exper.                   Control 
Traders              16             33                              11 (68.8)               14 (42.4) 
Unskilled  
workers              13             9                                 8 (61.5)                6 (66.7) 
Professionals      43            12                             18 (41.9)             4 (33.3) 
Full –time  
housewives          15             6                               4 (26.7)              1 (16.7)                                
 
 
Table IV: Occurrence of Candida species in women who used contraceptive and those who did not. 
 
 
Index                  Sample size            No. of positive cultures         % of pos. cultures 
Used contra.            36                            21                                     58.3 
Never used contra.  51                           18                                     35.3 
 
Age distribution of patients with 
Candida  showed isolation rates of 
51.7,43.5, and 36.4%   among age 17-23, 
24-30 and 31-37 years, respectively (Tab. 
II). Among occupational groups, traders  
 
had the highest occurrence of Candida 
species (68.8%) while full-time 
housewives had the lowest (26.7%) as 
shown in Tab. III. Women who used 
contraceptive pill had higher occurrence  
(58.3%) than those who never used 
contraceptive (35.3%, Tab. IV). 
Discussion 
Out of the 87 samples 44.8% were 
positive while for controls 46.7% were 
Candida-positive. These rates are high 
and compare well with earlier reports 
(13, 14). Candida albicans was most 
frequently isolated; this distribution is 
close to the result reported before (15, 
16). Although C. albicans is widely 
reported in literature to be the most 
frequently isolated Candida species (4, 
17) other Candida species are now being 
isolated with high rates (12, 14). Candida 
albicans produces protease, phosphatase 
and carbohydrates which enhance its 
attachment to human epithelium 
(18,19). Although such factors are also 
being studied in other Candida species, 
information on non-albicans Candida 
species is still scanty (19, 20). 
Women in the second trimester had the 
highest occurrence of Candida infection 
(68.8%). It is likely that the conditions, 
such as pH and temperature, which 
encourage colonisation by Candida, are 
enhanced as age of pregnancy increases.  
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The distributions of infection among all 
age groups except 38 - 44 years were 
similar. These three age groups with 
high occurrence of infection were also 
the ones reported earlier to be the most 
affected;  20-25 years  (21) and  21-30 
years (12). Although, these authors’ 
reports were based on non-pregnant 
women, the same factors namely, high 
sexual activity and child-bearing are 
attributable. This is corroborated by our 
results showing no significant 
difference (p=0.05) between age 
distribution of occurrence among 
pregnant women and non-pregnant 
women (control). 
Traders had the highest occurrence; this 
agrees with earlier report  (22). Traders 
usually have cash and due to their busy 
work, they might easily yield to self-
medication and drug misuse which is a 
factor that increases the rate of 
colonisation by Candida. The difference 
in results for women who used 
contraceptives and those who never 
used was significant (p = 0.05). Use of 
oral contraceptive pill has been reported 
to increase the occurrence of Candida 
infection of the vagina (4, 5, 7). 
There are indications that the factors 
studied here affect the rate of isolation 
of Candida species from pregnant 
women.  
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